<DOC>
	<DOCNO>NCT00263653</DOCNO>
	<brief_summary>The purpose study evaluate safety , reactogenicity immunogenicity booster dose candidate Hib-MenC conjugate vaccine give concomitantly measles , mumps rubella ( MMR ) vaccine , versus Hib-MenC MMR , give healthy subject age 13 14 month prim 3 dos Hib ( part DTPa -containing vaccine ) MenC-CRM197 .</brief_summary>
	<brief_title>Safety , Reactogenicity &amp; Immunogenicity Study Evaluate Booster Dose GSK Biologicals ' Hib-MenC Given With Priorix™ Toddlers ( 13-14 ) Primed With 3 Doses Hib MenC-CRM197</brief_title>
	<detailed_description>This multicenter study open respect treatment allocation , double-blind respect Hib-MenC-TT lot ( 3 lot ) . Hib-MenC-TT Priorix™ , give separately , serve active control . Two blood sample take : one month vaccination . Additional vaccine offer study end order complete vaccine schedule recommend Spain</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion : Healthy male female , include , 13 14 month age . Previously complete 3dose primary vaccination MenCCRM197 vaccine , Hib ( give part combine DTPacontaining vaccine ) least 6 month administration third dos study entry . Exclusion criterion : Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede study vaccine , plan use study period . Previous vaccination OR history H. influenzae type b ( Hib ) and/or meningococcal serogroup C disease and/or measles , mumps rubella OR know exposure measles , mumps rubella within 30 day prior start present study . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection . A family history congenital hereditary immunodeficiency . History neurologic disorder seizure . History allergic disease reaction likely exacerbate component vaccine include neomycine</criteria>
	<gender>All</gender>
	<minimum_age>13 Months</minimum_age>
	<maximum_age>14 Months</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>